1. Home
  2. TY vs MNKD Comparison

TY vs MNKD Comparison

Compare TY & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TY
  • MNKD
  • Stock Information
  • Founded
  • TY 1929
  • MNKD 1991
  • Country
  • TY United States
  • MNKD United States
  • Employees
  • TY N/A
  • MNKD N/A
  • Industry
  • TY Finance Companies
  • MNKD Biotechnology: Pharmaceutical Preparations
  • Sector
  • TY Finance
  • MNKD Health Care
  • Exchange
  • TY Nasdaq
  • MNKD Nasdaq
  • Market Cap
  • TY 1.6B
  • MNKD 1.4B
  • IPO Year
  • TY N/A
  • MNKD 2004
  • Fundamental
  • Price
  • TY $31.42
  • MNKD $3.74
  • Analyst Decision
  • TY
  • MNKD Buy
  • Analyst Count
  • TY 0
  • MNKD 4
  • Target Price
  • TY N/A
  • MNKD $9.75
  • AVG Volume (30 Days)
  • TY 43.0K
  • MNKD 3.2M
  • Earning Date
  • TY 01-01-0001
  • MNKD 08-06-2025
  • Dividend Yield
  • TY 3.36%
  • MNKD N/A
  • EPS Growth
  • TY N/A
  • MNKD 228.27
  • EPS
  • TY 4.78
  • MNKD 0.10
  • Revenue
  • TY N/A
  • MNKD $297,595,000.00
  • Revenue This Year
  • TY N/A
  • MNKD $13.72
  • Revenue Next Year
  • TY N/A
  • MNKD $15.21
  • P/E Ratio
  • TY $6.38
  • MNKD $35.96
  • Revenue Growth
  • TY N/A
  • MNKD 32.50
  • 52 Week Low
  • TY $25.16
  • MNKD $3.63
  • 52 Week High
  • TY $30.73
  • MNKD $7.63
  • Technical
  • Relative Strength Index (RSI)
  • TY 58.42
  • MNKD 37.31
  • Support Level
  • TY $30.94
  • MNKD $3.70
  • Resistance Level
  • TY $31.67
  • MNKD $4.00
  • Average True Range (ATR)
  • TY 0.40
  • MNKD 0.16
  • MACD
  • TY -0.03
  • MNKD 0.01
  • Stochastic Oscillator
  • TY 59.30
  • MNKD 22.00

About TY Tri Continental Corporation

Tri-Continental Corp is a United States-based closed-end management investment company. It invests to produce future growth of both capital and income while providing reasonable current income. The fund is divided into two equal segments namely, the equity segment uses quantitative models to select individual stocks whereas the Flexible capital income segment invests across a company's investable capital structure, including stocks, bonds, and convertible securities. The Fund invests in a range of sectors, which include consumer discretionary, consumer staples, energy, financials, healthcare, industrials, information technology, industrials, materials, real estate, telecommunication services, utilities, aerospace and defense, banking, chemicals, and others.

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

Share on Social Networks: